Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

RTTNews | 1034 hari yang lalu
Stocktwits
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

(RTTNews) - Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.

Fiscal 2023, the company continues to expect total revenue between $250 million and $260 million, with Cell Engineering revenue between $145 million and $150 million as well as Biosecurity revenue up to $110 million.

The company added that New Cell Programs are expected to be within the previously disclosed guidance range of 80 to 85 new Cell Programs added to the platform in 2023.

A business review, including a discussion of Ginkgo's platform services for large scale data generation and AI to enable biopharma R&D, will be featured in a presentation.

Tag: DNA
Stocktwits
baca selengkapnya
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews | 943 hari yang lalu
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews | 1569 hari yang lalu
Yen Falls Against Majors

Yen Falls Against Majors

The Japanese yen weakened against other major currencies in the Asian session on Tuesday.
RTTNews | 1 jam 13 menit yang lalu
European Shares Seen Mostly Higher At Open

European Shares Seen Mostly Higher At Open

European stocks are seen opening mostly higher on Tuesday after U.S. benchmark indexes saw their biggest rally in over seven months overnight, led by technology firms.
RTTNews | 3 jam 31 menit yang lalu
Perangkat
Kalender Ekonomi
Jam pasar
Suku bunga
Kalender hari libur
Pasar Valas
Volatilitas Forex
Korelasi Forex
Berita Forex
Analisis Forex
Data COT
Likuiditas
Kalkulator Forex
Peta Panas Forex
Indikator ekonomi Konverter mata uang
Komunitas
Komunitas
Sistems
Sistem Paling Populer
Strategi
Kontes
Grafik Forex
Sentimen Forex
Indikator Sentimen
Reviu
Pialang
Perusahaan Prop Trading
Layanan VPS
Penyedia Sinyal
Layanan Pemrograman EA
Program Afiliasi
Layanan Broker PAMM
Layanan Program Rebate
Platform Trading
Expert Advisor
Bursa Kripto
Kursus trading
Pelacak Portofolio Saham
Alat Trading AI
Pialang
Spread Forex
Kutipan Broker Forex
Swap Broker Forex
Volume Broker Forex
Promosi Broker Forex
Siaran Pers
Platform
Widget
Fitur
API
RSS
Stock Portfolio
Affiliate Software
Grafik Lanjutan
Dukungan
FAQ
Bantuan
Hubungi Kami
Laporkan Bug!
Tentang
Blog
© 2026 Myfxbook Ltd. Hak Cipta Dilindungi.
PERINGATAN RISIKO TINGGI: Perdagangan valuta asing memiliki tingkat risiko tinggi yang mungkin tidak sesuai untuk semua investor. Leverage meningkatkan risiko dan potensi kerugian. Sebelum memutuskan untuk trading forex, pertimbangkan dengan saksama tujuan investasi, tingkat pengalaman, dan toleransi risiko Anda. Anda dapat kehilangan sebagian atau seluruh investasi awal Anda. Jangan investasikan uang yang tidak sanggup Anda tanggung kehilangannya. Pelajari risiko yang terkait dengan trading forex dan mintalah saran dari penasihat keuangan atau pajak independen jika Anda memiliki pertanyaan. Semua data dan informasi disediakan 'apa adanya' semata-mata untuk tujuan informasi, dan tidak dimaksudkan untuk tujuan perdagangan atau sebagai nasihat. Kinerja masa lalu bukan merupakan indikasi hasil di masa mendatang.